LitAlert ~~ GeneLit.com

    • Examining the prevalence of homologous recombination repair defects in ER+ breast cancers.
    • Moore GM, Powell SN, Higginson DS, Khan AJ.
    • Breast Cancer Res Treat. 2022 Jan 29. doi: 10.1007/s10549-022-06529-z. Epub ahead of print.
    • BRCA1/2 Mutations in Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome.
    • Le TNN, Tran VK, Nguyen TT, Vo NS, Hoang TH, Vo HL, Nguyen THT, Nguyen PD, Nguyen VT, Ta TV, Tran HT.
    • Genes (Basel). 2021 Sep 29;13(2):268. doi: 10.3390/genes13020268.
    • Determinants of Response to Talazoparib in Patients with HER2-negative, Germline BRCA1/2-mutated Breast Cancer.
    • Blum JL, Laird AD, Litton JK, Rugo HS, Ettl J, Hurvitz SA, Martín M, Roché HH, Lee KH, Goodwin A, Chen Y, Lanzalone S, Chelliserry J, Czibere A, Hopkins JF, Albacker LA, Mina LA.
    • Clin Cancer Res. 2022 Jan 28:clincanres.2080.2021. doi: 10.1158/1078-0432.CCR-21-2080. Epub ahead of print.
    • Tumor Genomic Testing for >4000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib).
    • Hussain M, Corcoran C, Sibilla C, Fizazi K, Saad F, Shore N, Sandhu S, Mateo J, Olmos D, Mehra N, Kolinsky MP, Roubaud G, Ozgüroglu M,Matsubara N, Gedye C, Choi YD, Padua C, Kohlmann A, Huisden R, Elvin JA, Kang J, Adelman CA, Allen A, Poehlein C, de Bono J.
    • Clin Cancer Res. 2022 Jan 26. doi: 10.1158/1078-0432.CCR-21-3940. Epub ahead of print.